BRIEF published on 05/30/2024 at 10:21, 5 months 22 days ago Freelance.com prepares its General Meeting of June 14, 2024 Shareholders Freelance.com General Assembly Preparatory Documents Paris La Défense
BRIEF published on 05/20/2024 at 20:09, 6 months ago Freelance.com: 1st Quarter 2024 Revenue Increases by 24% Financial Results Revenue Growth Freelance.com Q1 2024
PRESS RELEASE published on 05/20/2024 at 20:04, 6 months ago Freelance.com: 1 st quarter 2024 revenue: €258.2m (+24%) Freelance.com reports €258.2m revenue (+24%) in 1st quarter 2024, with growth in France and international markets. Strategic acquisitions and positive organic growth contribute to market positioning Revenue Acquisitions Organic Growth Freelance.com 1st Quarter 2024
BRIEF published on 04/22/2024 at 18:45, 6 months 28 days ago Freelance.com Reports Notable Growth in 2023 Financial Results Economic Uncertainty 2023 Financial Results EBITDA Increase Freelance.com Financial Growth
PRESS RELEASE published on 04/22/2024 at 18:40, 6 months 28 days ago Freelance.com: 2023 results; strong EBITDA growth (+9%) Freelance.com reports 2023 revenue of €857.7m (+7%) with strong EBITDA growth (+9%). Financial results show positive trends and strategic acquisitions. Shareholders' equity strengthens to €153.6m 2023 Revenue Strategic Acquisitions Freelance.com EBITDA Growth Shareholders' Equity
BRIEF published on 02/26/2024 at 11:09, 8 months 24 days ago Freelance.com announces growth in its turnover in 2023 Outlook 2024 Growth Turnover Freelance.com French Market
PRESS RELEASE published on 02/26/2024 at 11:09, 8 months 24 days ago Freelance.com: 2023 Revenue: €857,7m (+7%) Freelance.com reports a 7% increase in revenue for 2023, reaching €857.7 million, with 4th quarter revenue up 10% at €239.8 million. Bright outlook for 2024 with recent acquisitions boosting growth Revenue Acquisitions 2023 Growth Freelance.com
BRIEF published on 02/26/2024 at 11:09, 8 months 24 days ago Freelance.com Records Growth in Turnover in 2023 Acquisitions Talent Management Growth Turnover Freelance.com
BRIEF published on 02/20/2024 at 17:45, 9 months ago Freelance.com Unveils its Financial Communication Calendar for 2024-2025 Financial Results TaaS Freelance.com Financial Communication Future Of Work
PRESS RELEASE published on 02/20/2024 at 17:45, 9 months ago Freelance.com: Financial Communication Agenda 2024-2025 Freelance.com presents its Financial Communication Agenda 2024-2025, including key publication dates for financial results and meetings. The calendar may be subject to change Euronext Growth Freelance.com Financial Communication Agenda 2024-2025 Talent As A Service
Published on 11/21/2024 at 13:30, 34 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 34 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 4 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 28 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 49 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 6 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 44 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 19 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 19 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
